Neuroleptic Malignant Syndrome: A Primary Care Perspective.
In recent years, there has been an increased use of neuroleptic agents in the primary care setting. Neuroleptic malignant syndrome (NMS) is a rare complication of neuroleptic therapy that can be missed if not suspected. This manuscript reviews the diagnosis and management of NMS in the primary care setting. There is a lack of prospective data, and most of the information is obtained from case series. Physicians need to have a high index of suspicion with regard to excluding NMS in patients taking neuroleptics and presenting with hyperthermia.
Gupta
Sanjay
S
Department of Psychiatry, University of Buffalo, School of Medicine and Biomedical Sciences, Buffalo, N.Y., and the Department of Psychiatry, Olean General Hospital, Olean, N.Y. ; and Strong Memorial Hospital, Rochester, N.Y .
Nihalani
Nikhil D
ND